Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial.
Journal: Neurology. Clinical practice
Published: May 13, 2026
Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 06, 2026
Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trial.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 23, 2026
18F-flortaucipir PET imaging: Biodistribution in the Japanese population and diagnostic accuracy by Japanese readers.
Journal: Annals of nuclear medicine
Published: February 16, 2026
Design and Fabrication of Guiding Patterns for Topography-Based Searching of 2D Devices for Scanning Tunneling Microscopy Measurements.
Journal: Small methods
Published: January 28, 2026
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Journal: JAMA neurology
Published: October 13, 2025
Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease.
Journal: Annals of neurology
Published: September 23, 2025
The pineal gland in ageing and alzheimer's disease: age-related molecular changes.
Journal: Brain structure & function
Published: June 07, 2025
Interchangeability of CSF and PET to identify Alzheimer's disease pathology.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: March 28, 2025
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials.
Journal: JAMA neurology
Published: March 10, 2025
Accelerating Discovery of Solid-State Thin-Film Metal Dealloying for 3D Nanoarchitecture Materials Design through Laser Thermal Gradient Treatment.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: February 10, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 07, 2025
Last Updated: 09/26/2026